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Abstract
Aging is associated with marked changes in the timing, consolidation and structure of sleep. Older people wake up frequently, get up
earlier and have less slow wave sleep than young people, although the extent of these age-related changes differs considerably between
individuals. Interindividual differences in homeostatic sleep regulation in young volunteers are associated with the variable-number,
tandem-repeat (VNTR) polymorphism (rs57875989) in the coding region of the circadian clock gene PERIOD3 (PER3). However,
predictors of these interindividual differences have yet to be identified in older people. Sleep electroencephalographic (EEG) characteristics
and circadian rhythms were assessed in 26 healthy older volunteers (55–75 years) selected on the basis of homozygosity for either the long
or short allele of the PER3 polymorphism. Homozygosity for the longer allele (PER35/5) associated with a phase-advance in the circadian
melatonin profile and an earlier occurrence of the melatonin peak within the sleep episode. Furthermore, older PER35/5 participants
accumulated more nocturnal wakefulness, had increased EEG frontal delta activity (0.75–1.50 Hz), and decreased EEG frontal sigma
activity (11–13 Hz) during non-rapid eye movement (REM) sleep compared with PER34/4 participants. Our results indicate that the
polymorphism in the clock gene PER3 may contribute to interindividual differences in sleep and circadian physiology in older people.
© 2012 Elsevier Inc. All rights reserved.
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1. Introduction
Aging is associated with numerous changes in sleep,
such as increased number and duration of awakenings, and
reduced time spent in slow wave sleep (SWS), as well as
earlier wake-up time (Cajochen et al., 2006; Dijk et al.,
1999). The decline in sleep consolidation, together with the
advance of sleep timing, may reflect age-related changes in
the homeostatic and/or circadian aspects of sleep regulation
(Cajochen et al., 2006; Dijk et al., 1999). From the sleep
homeostatic perspective, older people display a shallower
dissipation of sleep pressure, as indexed by reduced SWS
and slow wave activity (SWA) (electroencephalographic
[EEG] power density between 0.75 and 4.5 Hz, also referred
to as delta activity) dynamics across the night (Dijk and
Beersma, 1989; Landolt et al., 1996). From a circadian
standpoint, aging can be associated with a reduced circadian
amplitude of the core body temperature (CBT) rhythm, and
a phase advance of the CBT and melatonin rhythm (Dijk
et al., 1999). However, changes in circadian parameters
with aging are less consistent than age-related changes of
sleep parameters, and SWS in particular. Thus, some
(Czeisler et al., 1992; Münch et al., 2005; Van Coevorden et
al., 1991; Weitzman et al., 1982), but not all, studies report
a decline in the amplitude of CBT, melatonin, and cortisol
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(Monk, 2005; Niggemyer et al., 2004; Zeitzer et al., 1999).
The disparity of these findings points to rather large inter-
individual differences in sleep and circadian rhythmicity
with age and leaves the question open as to what is driving
these individual differences (Van Cauter et al., 2000). Prog-
ress in understanding the genetic and molecular basis of
sleep and circadian rhythmicity has led to the identification
of genes contributing to interindividual differences in sleep
architecture, timing, and duration in humans and mice
(Franken and Dijk, 2009; Landolt, 2008; Rétey et al., 2005).
The primate-specific (Jenkins et al., 2005), variable-
number tandem-repeat (VNTR) polymorphism within the
coding region of the clock gene PERIOD3 (PER3) contains
a 54-nucleotide unit that is repeated 4 (PER34 allele) or 5
(PER35 allele) times in humans (Ebisawa et al., 2001). In
young people, the PER3 VNTR predicts diurnal preference
such that those homozygous for the long repeat (PER35/5)
prefer earlier wake-up and sleep time (Archer et al., 2003;
Lázár et al., in press). Furthermore, in young people, the
PER3 VNTR polymorphism also predicts interindividual
differences in sleep structure and EEG power density in
non-rapid eye movement (REM) sleep, REM sleep and
wakefulness (Viola et al., 2007). PER35/5 individuals spent
more time in SWS, have higher SWA in non-REM sleep,
and a steeper dissipation of SWA during sleep episode as
compared with those homozygous for the shorter, 4-repeat
allele (PER34/4) (Viola et al., 2007). However, in young
people, we did not observe significant differences between
the genotypes with respect to the phase and amplitude of
circadian markers, such as the hormones cortisol and mela-
tonin and the clock genes PER3, BMAL1, and PER2 (Archer
et al., 2008; Dijk and Archer, 2010; Viola et al., 2007).
Since the PER3 VNTR polymorphism affects sleep reg-
ulation in young individuals, we tested the hypothesis
whether this polymorphism also predicts interindividual dif-
ferences in sleep of older people. Specifically, we predicted
that older participants homozygous for the longer repeat
(PER35/5) exhibit more slow wave sleep and higher EEG
power density in the delta frequency range than older par-
ticipants homozygous for the shorter repeat (PER34/4).
2. Methods
2.1. Study protocol
Recruitment of volunteers was conducted through adver-
tisements in newspapers, e-mails, radio, and posted adver-
tisements in the Basel and Alsace areas. The screening
procedure began with an interview by telephone or in per-
son, involving a detailed explanation of the study. A total of
168 older men and women (age range: 55–75 years) were
recruited, from whom DNA samples and questionnaire data
were collected. All participants gave written informed con-
sent. The study protocol, screening questionnaires, and con-
sent forms were approved by the local ethics committee
(EKBB, Basel, Switzerland) and conformed to the Decla-
ration of Helsinki. All potential study participants were
questioned about their sleep quality, life habits, and health
state. They completed a consent form, the General Medical
Questionnaire, the Short Form-36 (SF-36) Quality of Life
Questionnaire, the Horne-Östberg Questionnaire, the Mu-
nich Chronotype Questionnaire, the Pittsburgh Sleep Ques-
tionnaire, the Epworth Sleepiness Scale, the Beck Depres-
sion Inventory, and the Insomnia Severity Index
Questionnaire. Exclusion criteria were medical and sleep
disorders, smoking, medication or drug consumption, shift
work within the last 3 months, and transmeridian flights
during 2 months before the study.
For the genotyping, all potential participants provided
buccal swab samples, from which genomic DNA was ex-
tracted via the QuickExtract system (Epicentre Biotechnol-
ogies, Madison, WI, USA). Genotyping was performed with
polymerase chain reaction (PCR) as previously described
(Archer et al., 2003) with some modification (Vandewalle et
al., 2009).
Volunteers with good general health were included in the
field study. Forty participants wore actigraphs (wrist-worn
Actiwatch L, Cambridge Neurotechnology, Cambridge,
UK) to quantify their rest-activity profile and completed
daily sleep diaries for approximately 3 weeks prior to the
laboratory study. Complete data were obtained from 37
subjects, out of which 21 were PER35/5 (8 men, 13 women,
mean  standard error of the mean [SEM]  63.02  1.18,
in years) and 16 were PER34/4 participants (8 men, 8
women, mean  SEM  63.38  1.28, in years). The first
2 weeks were analyzed to characterize the habitual sleep-
wake cycle for each study participant, who was then in-
structed to sleep and wake-up according to his/her habitual
schedule for 1 week prior to the laboratory study. Compli-
ance was verified by analysis of the sleep diaries and actig-
raphy data prior to the laboratory study. Participants who
successfully completed the 3-week actigraphy underwent a
medical examination, blood screening, and a polysomnog-
raphy recorded adaptation night to exclude sleep disorders.
Exclusion criteria were  10 periodic leg movements per
hour and an apnea-hypopnea index  10. Thirteen PER34/4
individuals and 13 PER35/5 individuals were matched by
age, body mass index, gender, and ethnicity and included in
the laboratory part of the study. Table 1 describes the main
demographic characteristics of these participants, together
with data derived from questionnaires and the sleep-wake
timings derived from sleep diaries.
2.2. Laboratory study
The laboratory part consisted of a baseline sleep episode,
followed by approximately 40 hours of extended wakeful-
ness under constant routine (CR) conditions, and a subse-
quent recovery sleep episode. The CR protocol (Duffy and
Dijk, 2002a) was employed to assess the circadian phase
and amplitude as well as homeostatic aspects of sleep reg-
ulation, which involved 40 hours of extended wakefulness
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under constant environmental conditions (i.e., light  8 lux
at eye level, temperature approximately 21 °C, regular small
isocaloric meals and water, semirecumbent position during
scheduled wakefulness, and no information of clock time).
CBT was continuously recorded at 20-second intervals
using an indwelling rectal probe (Interstar, Cham, Switzer-
land; Therm, type 5500-3, Ahlborn, Holzkirchen, Gemany).
The temperature was displayed on a personal computer
screen and continuously monitored by a laboratory techni-
cian. Hourly saliva samples were collected to measure mela-
tonin and cortisol. All participants received heparin (0.2 mL
Fragmin, Pfizer, New York NY, USA) at the beginning of
the CR and 20 hours afterward, to avoid possible throm-
bosis. They were attended by technicians throughout the
entire CR.
2.3. Polysomnography measures
The Vitaport ambulatory system (Vitaport-3 digital re-
corder, TEMEC Instruments BV, Kerkrade, the Nether-
lands) was used for all polysomnography recordings. Eight
EEG channels (F3, F4, C3, C4, P3, P4, O1, O2) referenced
against linked mastoids (A1, A2), 2 electro-oculograms, 2
submental electromyograms, and 2 electrocardiograms were
recorded. All EEG signals were low pass filtered at 30 Hz
(fourth order Bessel type antialiasing, total 24 decibels per
octave) at a time constant of 1.0 second. After online dig-
itization by using a 12-bit analog-to-digital converter (0.15
V/bit) and a sampling rate at 128 Hz for the EEG, the raw
signals were stored on a Flash RAMCard (Viking, Rancho
Santa Margarita, USA) and later downloaded to a PC hard
drive. Sleep stages were visually scored per 20-second ep-
ochs (Vitaport Paperless Sleep Scoring Software, Kerkrade,
the Netherlands) according to standard criteria (Re-
chtschaffen and Kales, 1968) by a single experienced poly-
somnography technician, blind to the genotype. Sleep stages
were reported as percentages of total sleep time (TST).
Sleep latency was defined as latency from lights off to the
first epoch of stage 2. Slow wave sleep was defined as the
sum of stages 3 and 4 and non-REM sleep as the sum of
stages 2, 3, and 4.
Spectral analysis was conducted using a fast Fourier
transform (FFT; 10% cosine 4-second window) which
yielded a 0.25-Hz resolution. To examine EEG power den-
sity in the range of 0.75–20 Hz during non-REM and REM
sleep for both genotypes, all-night EEG power density dur-
ing the baseline and recovery nights was computed for
frontal (F3, F4), central (C3, C4), parietal (P3, P4), and
occipital (O1, O2) derivations for each 0.25-Hz frequency
bin. To further explore the effects of the 40 hours of ex-
tended wakefulness between the genotypes, we computed
the difference of recovery and baseline non-REM sleep
EEG power density from 0.75 to 20 Hz in PER34/4 and
PER35/5 individuals. Data of frontal EEG power density
during recovery sleep was excluded for 1 participant due to
artifacts across the entire night.
2.4. Hormonal assays
Saliva collections for melatonin and cortisol were sched-
uled every 60 minutes, during the 40 hours of extended
wakefulness. A direct double-antibody radioimmunoassay
was utilized for the melatonin assay (validated by gas chro-
matography mass spectroscopy with an analytical least de-
tectable dose of 0.65 pm/mL; Bühlmann Laboratory,
Schönenbuch, Switzerland) (Weber et al., 1997). Cortisol
was measured by ALPCO (American Laboratory Products
Company Diagnostics, Salem, NH, USA), using a direct
salivary enzyme-linked immunosorbent assay (ELISA) for
quantitative determination of cortisol by enzyme immuno-
assay. Sensitivity was 1.0 ng/mL and intra-assay coefficient
of variances was 10.3% for baseline values (b) 6.6 ng/mL.
2.5. Statistical analysis
All statistical analyses were performed with SAS version
9.1 (SAS Institute, Cary, NC, USA). To examine EEG
power density in the range of 0.75–20 Hz during non-REM
sleep for both genotypes, all-night EEG power density dur-
ing the baseline and recovery nights was computed for
frontal, central, parietal, and occipital derivations for each
0.25-Hz frequency bin. Comparisons between genotypes
were made with mixed-model analyses of variance for re-
peated measures (PROC Mixed), with factors “genotype”
(PER34/4 and PER35/5), “night” (baseline and recovery),
“time,” and “derivation” (frontal F3 and F4; central C3
and C4; parietal  P3 and P4; occipital  O1 and O2).
Contrasts were assessed with the LSMEANS statement. All
p-values were based on Kenward-Roger’s corrected degrees
of freedom. To investigate the decay of non-REM EEG
delta-power density, we first performed a detection of each
quarter Hz within the delta frequency range (0.75–4.0 Hz)
that had a significant “genotype” effect (0.75–1.50 Hz). This
Table 1
Demographic and sleep-wake characteristics
Genotype PER35/5
(n  13)
PER34/4
(n  13)
p
Gender, M/F 5/8 5/8
Age 62.38  1.39 62.23  1.01 0.93
BMI 25.58  0.76 24.91  0.81 0.55
MCTQ 3.17  0.21 3.51  0.17 0.21
PSQI 3.45  0.43 3.17  0.46 0.65
Sleep time 22:42 00:11 22:50  00:12 0.64
Wake time 06:59 00:20 07:05  00:11 0.78
Time in bed 08:17 00:20 08:15  00:16 0.96
HO 64.22  2.70 64.00  2.62 0.95
BDI 3.89  0.87 4.00  1.61 0.95
ESS 6.44  0.88 9.40  1.06 0.04
ISI 9.67  2.35 9.40  2.06 0.93
Sleep time, wake-up time, and time in bed derived from sleep diaries
(mean  standard error of the mean [SEM]).
Key: BDI, Beck Depression Inventory; BMI, body mass index; ESS,
Epworth Sleepiness Scale; F, female; HO, Horne-Östberg Questionnaire;
ISI, Insomnia severity index; M, male; MCTQ, Munich Chronotype Ques-
tionnaire; PSQI, Pittsburgh Sleep Questionnaire.
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delta range was then utilized to assess the decay of delta
activity (on absolute values) for the first 6 hours after sleep
onset for EEG of baseline and recovery nights between the
genotypes. An exponential decay function (PROC NLIN, SAS
9.1) was fitted as follows: delta  delta  delta0  e–r/t,
whereby delta0  intercept on y axis, delta  EEG delta
power per hour, r slope of decay, t time of hour midpoint.
For the analysis of circadian variables such as CBT,
melatonin, cortisol, and rest-activity we used a number of
approaches. To estimate whether there was an overall effect
of genotype, we applied a 2-way r-analysis of variance
(ANOVA) with factors “genotype” and “time,” the alpha
adjustment for multiple comparisons was applied according
to Curran-Everett (2000). To estimate the timing and am-
plitude of rhythmic functions of these circadian variables,
we also used a nonlinear regression procedure (PROC
NLIN, SAS 9.1), whose function fitted to the data was:
Value (sample ti)  Mesor  Amplitude  sin ((sample
ti-phase)/24.2) in which the mesor, amplitude, and phase
were free parameters, ti represents the clock time i at which
a sample was collected, and value represents the value of the
circadian marker variable. Determination of a fitted function
for CBT was based on the model: temp  Mesor  Am-
plitude  sin ((sample ti-phase)/24.2) for the analyses of
cortisol and melatonin, data were z-scored to provide a
normalized comparison of amplitudes across these vari-
ables. This approach first equates the total variance in each
variable in each individual, and then determines how much
of this variance can be attributed to a circadian signal. The
phase of the melatonin rhythm and cortisol was defined on
the basis of the timing of the fitted maximum. In addition,
we estimated the phase of the melatonin rhythm, defined as
the time of the midpoint between the upward and downward
mean crossing. In each individual, the average concentra-
tion of melatonin was calculated and the time of the upward
and downward crossing of the mean was determined with
linear interpolation (Zeitzer et al., 1999). This method of
phase determination is robust against individual differences
in the amplitude of the melatonin rhythm. Circadian CBT
phase was defined as the fitted minimum. The phase angle,
or time interval, between habitual wake-up and sleep times
and circadian phase was calculated by subtracting the time
of fitted melatonin maximum from habitual wake-up and
sleep times for each subject (Duffy et al., 2002b).
3. Results
3.1. Demographic and sleep-wake characteristics
Table 1 summarizes the main demographic and sleep-
wake characteristics of the 13 PER34/4 and 13 PER35/5 older
individuals. Age, body mass index, chronotype, sleep qual-
ity, insomnia symptoms, as well as sleep time, wake-up
time, and time in bed (derived from the sleep diaries) were
typical for healthy older individuals with a relatively higher
morningness score. None of these variables differed signif-
icantly between the 2 genotypes, except the likelihood of
falling asleep during daytime, as assessed by the Epworth
Sleepiness scale, which was significantly higher in PER34/4
than for PER35/5 individuals (p  0.04).
3.2. Circadian markers: rest-activity cycle
Rest-activity cycles quantified by actigraphy during the
field study differed between the genotypes, such that the
ANOVA revealed a significant interaction for the factors “ge-
notype” and “time” (F  1.31; p  0.04) (Fig. 1). Further-
more, the assessment of the onset of activity by fitting a
rhythmic function to the data revealed a significant difference
between the genotypes, such that PER35/5 participants had an
earlier onset of activity, as compared with PER34/4 participants
(mean  SEM: PER35/5  04:42 00:51 and PER34/4 
06:54 00:25, in hours; t test; p  0.04).
3.3. Circadian markers: CBT, cortisol, and melatonin
Analyses of the circadian rhythms of CBT and cortisol
did not yield statistically significant differences between the
genotypes (Fig. 2). By contrast, the analysis of the mela-
tonin profile yielded a significant interaction for the factors
“genotype”  “time” (F  1.74; p  0.011). Furthermore,
estimation of circadian phase with a nonlinear regression
procedure yielded a significant phase advance of the fitted
melatonin maximum in the PER35/5 (mean  SEM  01:
52  00:11, in hours) compared with the PER34/4 partici-
pants (mean  SEM  02:40  00:18 in hours). These
results were corroborated by the significantly earlier mela-
tonin midpoint in the PER35/5 (mean  SEM  02:
18  00:15 in hours) compared with the PER34/4 volunteers
(mean  SEM  03:40  00:33 in hours; t test; p  0.03).
Analysis of the phase relationship between average wake-up
time and timing of melatonin midpoint yielded no signifi-
cant differences between the genotypes. However, the in-
terval between the average sleep time and melatonin mid-
Fig. 1. Double plot of average activity counts of rest-activity cycles
quantified by actigraphy (field study) in 21 PER35/5 participants (white
circles) and 16 PER34/4 (black circles). Data are shown as z-scores aver-
aged per 20-minute intervals (mean  standard error of the mean [SEM]).
The time course is plotted relative to time of day (local time).
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point was significantly shorter for PER35/5 (mean SEM
02:54  00:18, in hours) than for PER34/4 participants
(mean  SEM  03:44  00:12, in hours; t test; p  0.02).
3.4. Baseline and recovery sleep structure
A 2-way r-ANOVA yielded a significant interaction for
factors “genotype”  “night” for total sleep time (p 
0.04), and a trend for a significant interaction between these
factors for sleep efficiency (p 0.07) and wakefulness (p
0.06) (Table 2). Main effect “night” was significant for total
sleep time, sleep efficiency, non-REM stage 1, and SWS (%
of total sleep time) (p  0.05). When the analyses were
restricted to the baseline night, PER35/5 participants had
lower sleep efficiency, and more wakefulness than the
PER34/4 participants (p 0.05). Analysis of the time course
of sleep consolidation, as indexed by accumulated wakeful-
ness, revealed that PER35/5 participants had significantly
more wakefulness during baseline night than PER34/4 (Wil-
coxon 2-sample test p  0.05), after 4 hours of sleep onset
(Fig. 3, left panel). These results were further corroborated
by a 2-way r-ANOVA on the number of awakenings (per
hour), which yielded a significant “genotype” effect (F 
4.04; p  0.04) (Fig. 3, right panel).
3.5. Baseline and recovery sleep EEG power density
A 3-way r-ANOVA with the factors “genotype,” “deri-
vation,” and “night” yielded a significant main effect for the
factor genotype in the frequency range of 0.75 to 1.50 Hz
(delta range) and of 11 to 13 Hz (sigma range) (p  0.05).
The main effect of “night” was significant in the frequency
range of 0.75–10.25 Hz and 15.50–20 Hz (p  0.05). The
2-way interaction of the factors “genotype”  “derivation”
was significant in the frequency range of 0.75–6.5 Hz and
of 8.75–17.25 Hz (p  0.05). The 2-way interaction “ge-
notype”  “night” and the 3-way interaction “genotype” 
“night”  “derivation” yielded no significant differences.
Fig. 4 shows that, during the baseline night, PER35/5 indi-
viduals had higher frontal EEG power density in 0.75–1.50
Hz (delta range) than the PER34/4 individuals. Conversely,
during the baseline and recovery nights, PER35/5 individu-
als had lower frontal EEG power in 11–13 Hz (sigma range)
than the PER34/4 individuals. Furthermore, only during the
baseline night, PER35/5 individuals had higher occipital
EEG power density in the frequency range of 5–6 Hz.
Analysis of the effects of 40 hours of extended wakefulness
(difference of recovery and baseline nights) revealed no
significant differences in the response to sleep deprivation
in non-REM sleep EEG power density in the frequency
range from 0.75 to 20 Hz between PER34/4 and PER35/5
individuals (Fig. 5).
REM sleep EEG power density did not significantly
differ between the genotypes during either the baseline or
the recovery night (data not shown).
Given the differential levels of the absolute values of
delta activity between the genotypes, we computed the
exponential decay function (Delta Delta  Delta0 
e–r/t) for frontal non-REM delta activity (by hour), first on
an individual basis and then by computing the average
parameters for all-night duration of EEG of baseline and
recovery nights. A 2-way r-ANOVA yielded a significant
interaction for the factors “genotype”  “time” for delta
activity (F  2.89, p  0.04). Homozygosity for the longer
Fig. 2. Time course of core body temperature (top panel), salivary cortisol
(middle panel), and salivary melatonin (bottom panel) profiles (z-scores)
during 40 hours of extended wakefulness under constant routine conditions
in 13 PER35/5 participants (white circles) and 13 PER34/4 (black circles).
Horizontal bars in bottom panel illustrate the timing of the habitual sleep
period in PER35/5 (white bar) and PER34/4 (black bar) participants. Data
are plotted relative to time of day (local time), and the error bars represent
the standard error of the mean.
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allele (PER35/5) was associated with more delta activity in
the first 2 hours of the baseline night (first hour:
873.33  148.34 V2; second hour: 762.24 116.39 V2;
mean  SEM) than for PER34/4 participants (first hour:
577.83  90.49 V2; second hour: 558.44 77.93 V2;
mean  SEM; t test; p  0.05), and a significantly faster
dissipation rate (PER35/5: 5.2  1.2 hours vs. PER34/4:
11.6  2.7 hours [mean  SEM]; t test; p  0.05). After
challenging the sleep homeostat by 40 hours of extended
wakefulness, delta activity was increased in both the geno-
types. However, no significant differences between the ge-
notypes were observed for the amount of delta activity and
the rate of dissipation (Fig. 6).
4. Discussion
The data show that, in older individuals, the PER3
VNTR polymorphism significantly contributes to individual
differences in the rest-activity timing, circadian rhythmicity,
and the spectral composition of the EEG during non-REM
sleep. Homozygosity for the longer allele (PER35/5) was
associated with an earlier activity onset in the morning, an
earlier melatonin midpoint, and a shorter interval (phase-
angle) between the average sleep time and melatonin mid-
point. PER35/5 participants had reduced sleep efficiency and
more wakefulness; only during baseline sleep. PER35/5 par-
ticipants showed increased frontal non-REM delta (0.75–
1.50 Hz) and decreased frontal sigma activity (11–13 Hz)
during baseline sleep, while during recovery sleep only
frontal sigma activity was decreased. Furthermore, the re-
sponse to the effects of extended wakefulness was similarTa
bl
e
2
PS
G
Sl
ee
p
v
ar
ia
bl
es
du
rin
g
ba
se
lin
e
an
d
re
co
v
er
y
sle
ep
in
PE
R3
4/
4
an
d
PE
R3
5/
5
v
o
lu
nt
ee
rs
B
as
el
in
e
R
ec
ov
er
y
p-
v
al
ue
s
A
N
O
V
A
PE
R3
5/
5
(n

13
)
PE
R3
4/
4
(n

13
)
PE
R3
5/
5
(n

13
)
PE
R3
4/
4
(n

13
)
B
N G
en
e
R
N G
en
e
PE
R3
5/
5
n
ig
ht
PE
R3
4/
4
n
ig
ht
G
en
e
N
ig
ht
G
en
e

n
ig
ht
Ti
m
e
in
be
d
(m
in)
48
6.
26

7.
76
47
9.
13

10
.6
4
48
8.
38

8.
43
47
9.
36

13
.4
9
0.
63
0.
54
0.
62
0.
62
0.
58
0.
71
0.
76
To
ta
ls
le
ep
tim
e
(m
in)
37
8.
15

9.
22
40
5.
87

10
.2
2
42
7.
00

10
.4
4
42
3.
44

11
.3
9
0.
06
0.
81

0.
00
1
0.
11
0.
36

0.
00
1
0.
04
Sl
ee
p
ef
fic
ie
nc
y
77
.9
7

2.
11
84
.8
8

1.
88
87
.4
0

1.
47
88
.7
2

2.
14
0.
01
0.
63

0.
00
1
0.
09
0.
08

0.
00
1
0.
07
La
te
nc
y
to
st
ag
e
2
(m
in)
14
.4
1

2.
01
15
.0
0

2.
72
15
.3
6

4.
32
9.
87

2.
07
0.
89
0.
19
0.
79
0.
17
0.
46
0.
42
0.
24
La
te
nc
y
to
R
EM
sle
ep
(m
in)
96
.3
8

12
.2
6
77
.9
7

7.
69
84
.3
6

12
.4
9
79
.1
1

13
.8
4
0.
27
0.
71
0.
34
0.
99
0.
39
0.
51
0.
5
St
ag
e
1
(%
TS
T)
20
.0
4

1.
82
18
.7
9

2.
25
12
.1
0

1.
48
11
.5
4

1.
41
0.
62
0.
82

0.
00
1

0.
00
1
0.
68

0.
00
1
0.
78
St
ag
e
2
(%
TS
T)
55
.5
4

2.
30
58
.9
4

2.
08
56
.9
1

3.
37
60
.7
7

2.
70
0.
37
0.
31
0.
66
0.
55
0.
25
0.
46
0.
91
SW
S
(%
TS
T)
8.
07

2.
23
5.
69

1.
61
14
.9
3

3.
45
10
.9
8

1.
97
0.
49
0.
26

0.
00
1
0.
01
0.
33

0.
00
1
0.
53
R
EM
sle
ep
(%
TS
T)
16
.3
4

1.
10
16
.5
8

1.
03
16
.0
5

1.
38
16
.7
1

2.
08
0.
91
0.
75
0.
87
0.
94
0.
78
0.
95
0.
86
W
ak
e
tim
e
du
ra
tio
n
(m
in)
10
1.
72

27
.8
7
66
.6
4

10
.1
0
52
.1
8

6.
83
48
.3
8

11
.7
4
0.
02
0.
79

0.
00
1

0.
00
1
0.
1

0.
00
1
0.
06
M
ea
n

SE
M
is
sh
ow
n;
p
v
al
ue
s
ar
e
fo
rt
he
co
m
pa
ris
on
o
ft
he
2
ge
no
ty
pe
s
o
r
o
ft
he
2
n
ig
ht
s.
K
ey
:A
N
O
V
A
,a
n
al
ys
is
o
fv
ar
ia
nc
e;
B
N
,b
as
el
in
e
n
ig
ht
;P
SG
,p
ol
ys
om
no
gr
ap
hi
c;
R
EM
,r
ap
id
ey
e
m
o
v
em
en
t;
R
N
,r
ec
o
v
er
y
n
ig
ht
;S
W
S,
slo
w
w
av
e
sle
ep
;T
ST
,t
ot
al
sle
ep
tim
e.
Fig. 3. Accumulation curves for minutes of wakefulness (left panel) after
sleep onset (non-rapid eye movement [REM] sleep stage 2) during baseline
and recovery nights in 13 PER35/5 (gray lines) and 13 PER34/4 (black lines)
participants. Mean  standard error of the mean (SEM) values are shown
for each 5-minute bin. Horizontal symbols near the abscissa at the bottom
indicate the time for which factor “genotype” (stars) and factor “night”
(open circles) were significant (p  0.05). Right panel illustrates the
number of awakenings (per hour) during baseline and recovery nights in
PER35/5 (gray bars) and PER34/4 (black bars) participants (mean  SEM
values; p  0.05).
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Fig. 4. Electroencephalographic (EEG) power density spectra during non-rapid eye movement (REM) sleep in frontal, central, parietal, and occipital
derivations during the baseline (left panel) and recovery night (right panel). All-night EEG power density values per 0.25-Hz bin during non-REM sleep in
PER35/5 participants are expressed as percentage of the corresponding average values in PER34/4 participants. The horizontal line represents 100% of EEG
power density in the PER34/4 participants. Mean standard error of the mean (SEM) values are shown for each 0.25-Hz frequency bin in the range of 0.75–20
Hz. Horizontal symbol near the abscissa at the bottom indicate frequency bins for which factor “genotype” (open stars) and factor “night” (open circles) were
significant. Open triangles show frequency bins for which the interaction “genotype”  “derivation” were significant (p  0.05). Horizontal stars at the top
of each panel indicate significant differences between the genotypes for those frequency bins.
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between the genotypes. Our current findings indicate that in
older participants both the circadian and the homeostatic
processes seem to be differentially affected by the PER3
VNTR. Thus, we replicated the previous finding in young
participants (Viola et al., 2007) that the PER3 polymor-
phism predicts interindividual differences in sleep (i.e., non-
REM delta activity) in an independent sample comprising
older participants. However, we did not replicate the in-
crease in visually scored SWS in young PER35/5, probably
due to the very low levels of SWS in older people. The
novel aspect of our current study in older people is that the
PER3 polymorphism also impacts on the timing of robust
circadian markers, such as melatonin.
As expected, the sleep and wake-up times of the current
sample of older people was earlier, with higher morningness
scores than in the group of young subjects (Viola et al.,
2007). The 2 genotype groups were stringently matched for
key demographic characteristics, such as age, body mass
index (BMI), etc. Thus, it is uncertain how the higher
daytime sleepiness score in PER34/4 participants relates to
the other genotype-dependent changes in sleep and circa-
dian variables. The advance of the melatonin profile and
shorter internal phase relationship between the sleep-wake
cycle and the melatonin rhythm indicate that PER35/5 older
volunteers slept later relative to the timing of the evening
increase in melatonin levels. It remains uncertain if these
changes in circadian phase and internal phase relationship in
older PER35/5 volunteers are driven by changes in the pe-
riod of the circadian oscillator, or differences in light sen-
sitivity or altered light exposure associated with sleep tim-
ing. Interestingly, we found no differences with respect to
the phase-angle of melatonin and wake-up time. Older par-
ticipants wake up earlier relative to the morning decline
in their melatonin levels (Duffy et al., 2002b) and the nadir
of the core body temperature rhythm (Duffy et al., 1998),
which suggests that older individuals may be waking up at
an earlier circadian phase. Furthermore, changes in the inter-
nal phase angle have also been observed in young morning
types (Duffy and Czeisler, 2002c) and the PER35/5 polymor-
phism is associated with morningness in young adults (Archer
et al., 2003; Lázár et al., in press). Thus, aging and diurnal
preference have been associated with changes in the phase
angle between sleep and the melatonin rhythm (Dijk and Lock-
ley, 2002), and our results imply that these changes are mod-
ulated by the PER3 VNTR polymorphism.
Aging is associated with a reduction of sleep consolida-
tion, with more awakenings in particular from non-REM
sleep, which suggests an attenuation of the protective non-
REM role for sleep with aging (Dijk et al., 2001). In our
study, sleep consolidation was lower in PER35/5 participants
than in PER34/4 in particular during the second half of the
baseline sleep, when homeostatic sleep pressure is low.
From a circadian perspective, the reduced sleep consolida-
tion in PER35/5 older participants may reflect a diminished
strength of the circadian drive for sleep.
Sigma activity, which correlates well with sleep spindle
activity (Dijk and Czeisler, 1995), was reduced in PER35/5
individuals. Sleep spindles comprise the interplay of retic-
ular thalamic, thalamocortical, and cortical pyramidal cells
(Steriade et al., 1993), and are under circadian control (Dijk
and Czeisler, 1995; Wei et al., 1999), such that the circadian
pacemaker actively promotes spindles during the night, pre-
sumably to promote sleep consolidation (Dijk and Czeisler,
1995). Sleep spindles have been described as inhibitory
events that can predict sleep stability (Dang-Vu et al.,
2010), and both its frequency and its circadian modulation
can decline with age (Dijk and Czeisler, 1995; Knoblauch et
al., 2005; Wei et al., 1999). Furthermore, the circadian
modulation of sleep spindle characteristics varies with brain
location, such that the major difference is between frontal
and parietal spindle frequency activity (Cajochen and Dijk,
2003). Frontal spindles were found to have a lower fre-
quency (approximately 12 Hz) than parietal spindles (ap-
proximately 14 Hz). The observation that our genotype
dependent changes in spindle activity were observed for a
lower frequency range (11–13 Hz), and that these differ-
ences were most apparent in frontal brain areas, may indi-
cate that the age-related decrease in sigma activity is mod-
ulated by the PER3 VNTR, presumably through changes in
the circadian promotion of spindle activity.
Homozygosity for the longer allele (PER35/5) affected
baseline EEG power density, with increased non-REM fron-
Fig. 5. Electroencephalographic (EEG) non-rapid eye movement (REM)
power density in the range of 0.75–20 Hz during the recovery night in 13
PER35/5 (gray lines) and 13 PER34/4 (black lines) participants expressed as
percentage of EEG power density during baseline (100%). Data are pre-
sented as mean  standard error of the mean (SEM).
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tal delta activity. At the beginning of sleep, delta activity,
particularly in frontal derivations, acts as a functional index
of increased homeostatic sleep pressure (Borbély et al.,
1981; Cajochen et al., 2001). Thus, our findings indicate
that, as for young individuals, the dynamics of the sleep
homeostatic process also differ between older PER35/5 and
PER34/4 individuals. Furthermore, in the absence of sleep
deprivation, PER35/5 individuals initiate sleep at a higher
homeostatic level and display a faster dissipation of this
sleep pressure. The lower dissipation rate in delta activity
observed in our older participants is in accordance with
previous observations and is largely independent of topog-
raphy (Münch et al., 2004). Interestingly, very large inter-
individual differences in the dissipation slope were ob-
served for the PER34/4 but not for PER35/5 participants,
particularly after sleep deprivation. Whether or not this is
related to other differences between the genotypes remains
unknown.
The topographical distribution of delta activity is such
that, during both sleep and wakefulness, the homeostatic
increase in low-EEG components is most prominent in
frontal brain areas (Cajochen et al., 1999; Finelli et al.,
2000), indicating higher susceptibility to the effects of sleep
deprivation. Our results on frontal delta activity indicate
that PER35/5 may experience higher sleep pressure, as com-
pared with PER34/4 participants, and that the frontal cortex
is the most susceptible to the effects of this higher sleep
pressure. With respect to the occipital derivation, to our
knowledge there are no previous studies that have shown
such frequency-unspecific changes in this derivation with
advanced age. Thus, the reason as to why we observed
higher EEG power density in PER35/5 participants (across
all frequency ranges) remains elusive. Aging affects both
the homeostatic and the circadian aspects of sleep, and the
present data seem to indicate that these age-related changes
are more prominent in PER35/5 older volunteers. Our study
sample did not include young PER35/5 and PER34/4 volun-
teers, thus we could not conduct a direct age-related com-
parison for the homeostatic and circadian changes. Further-
more, even a direct comparison would only constitute a
cross-sectional comparison and not establish whether the
PER3 VNTR interacts with the aging process per se, as this
would require a longitudinal study. The present data show
that key aspects of age-related changes in sleep and circa-
dian rhythmicity, such as earlier melatonin phase, shorter
phase-angle, reduced sigma activity, and sleep consolida-
tion, are more pronounced in PER35/5 older volunteers.
Thus, we speculate that PER35/5 individuals show more
distinct age-related changes commonly seen in sleep struc-
ture and circadian phase. These data have implications for
our understanding of the interindividual differences in age-
related changes in sleep and circadian rhythmicity.
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Fig. 6. Time course of frontal absolute delta activity during baseline (left panel) and recovery (right panel) nights. Lines represent an exponential decay
function (delta  delta  delta0  e–rt) of non-rapid eye movement (REM) electroencephalographic (EEG) delta power (0.75–1.5 Hz) fitted to the data
separately for the 2 genotypes. Dashed lines and white circles: PER35/5 participants; solid lines and black circles: PER34/4 participants. Data are plotted by
time (in hours) after sleep onset (non-REM sleep stage 2). * Significant difference between genotypes for the amount of absolute values of delta activity.
1010.e25A.U. Viola et al. / Neurobiology of Aging 33 (2012) 1010.e17–1010.e27
Acknowledgements
We thank Claudia Renz, Marie-France Dattler, and Gio-
vanni Balestrieri for their help in data acquisition. This
research was supported by the Velux Foundation (n°449,
Switzerland).
References
Archer, S.N., Robilliard, D.L., Skene, D.J., Smits, M., Williams, A.,
Arendt, J., von Schantz, M., 2003. A length polymorphism in the
circadian clock gene Per3 is linked to delayed sleep phase syndrome
and extreme diurnal preference. Sleep 26, 413–415.
Archer, S.N., Viola, A.U., Kyriakopoulou, V., Von Schantz, M., Dijk, D.,
2008. Inter-Individual differences in habitual sleep timing and en-
trained phase of endogenous circadian rhythms of BMAL1, PER2 and
PER3 mRNA in human leucocytes. Sleep 5, 608–617.
Borbély, A.A., Baumann, F., Brandeis, D., Strauch, I., Lehmann, D., 1981.
Sleep deprivation: effect on sleep stages and EEG power density in
man. Electroencephalogr. Clin. Neurophysiol. 51, 483–493.
Cajochen, C., Dijk, D.J., 2003. Electroencephalographic activity during
wakefulness, rapid eye movement, and non-rapid-eye movement sleep
in humans: comparison of their circadian and homeostatic modulation.
Sleep Biol. Rhythms 2, 85–95.
Cajochen, C., Foy, R., Dijk, D.J., 1999. Frontal predominance of a relative
increase in sleep delta and theta EEG activity after sleep loss in
humans. Sleep Res. Online 2, 65–69.
Cajochen, C., Knoblauch, V., Kräuchi, K., Renz, C., Wirz-Justice, A.,
2001. Dynamics of frontal EEG activity, sleepiness and body tem-
perature under high and low sleep pressure. Neuroreport 12, 2277–
2281.
Cajochen, C., Münch, M., Knoblauch, V., Blatter, K., Wirz-Justice, A.,
2006. Age-related changes in the circadian and homeostatic regulation
of human sleep. Chronobiol. Int. 23, 1–14.
Curran-Everett, D., 2000. Multiple comparisons: philosophies and illustra-
tions. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279, R1–R8.
Czeisler, C.A., Dumont, M., Duffy, J.F., Steinberg, J.D., Richardson, G.S.,
Brown, E.N., Sánchez, R., Ríos, C.D., Ronda, J.M., 1992. Association
of sleep-wake habits in older people with changes in output of circadian
pacemaker. Lancet 340, 933–936.
Dang-Vu, T.T., McKinney, S.M., Buxton, O.M., Solet, J.M., Ellenbogen,
J.M., 2010. Spontaneous brain rhythms predict sleep stability in the
face of noise. Curr. Biol. 20, R626–R627.
Dijk, D.J., Archer, S.N., 2010. PERIOD3, circadian phenotypes, and sleep
homeostasis. Sleep Med. Rev. 14, 151–160.
Dijk, D.J., Beersma, D.G., van den Hoofdakker, R.H., 1989. All night
spectral analysis of EEG sleep in young adult and middle-aged male
subjects. Neurobiol. Aging 10, 677–682.
Dijk, D.J., Czeisler, C.A., 1995. Contribution of the circadian pacemaker
and the sleep homeostat to sleep propensity, sleep structure, electroen-
cephalographic slow waves, and sleep spindle activity in humans.
J. Neurosci. 15, 3526–3538.
Dijk, D.J., Duffy, J.F., Czeisler, C.A., 2001. Age-related increase in awak-
enings: impaired consolidation of nonREM sleep at all circadian
phases. Sleep 24, 565–577.
Dijk, D.J., Duffy, J.F., Riel, E., Shanahan, T.L., Czeisler, C.A., 1999.
Ageing and the circadian and homeostatic regulation of human sleep
during forced desynchrony of rest, melatonin and temperature rhythms.
J. Physiol. 516, 611–627.
Dijk, D.J., Lockley, S.W., 2002. Integration of human sleep-wake regula-
tion and circadian rhythmicity. J. Appl. Physiol. 92, 852–862.
Duffy, J.F., Czeisler, C.A., 2002c. Age-related change in the relationship
between circadian period, circadian phase, and diurnal preference in
humans. Neurosci. Lett. 318, 117–120.
Duffy, J.F., Dijk, D.J., 2002a. Getting through to circadian oscillators: why
use constant routines? J. Biol. Rhythms 17, 4–13.
Duffy, J.F., Dijk, D.J., Klerman, E.B., Czeisler, C.A., 1998. Later endog-
enous circadian temperature nadir relative to an earlier wake time in
older people. Am. J. Physiol. 275, R1478–R1487.
Duffy, J.F., Zeitzer, J.M., Rimmer, D.W., Klerman, E.B., Dijk, D.J.,
Czeisler, C.A., 2002b. Peak of circadian melatonin rhythm occurs later
within the sleep of older subjects. Am. J. Physiol. Endocrinol. Metab.
282, E297–E303.
Ebisawa, T., Uchiyama, M., Kajimura, N., Mishima, K., Kamei, Y., Katoh,
M., Watanabe, T., Sekimoto, M., Shibui, K., Kim, K., Kudo, Y., Ozeki, Y.,
Sugishita, M., Toyoshima, R., Inoue, Y., Yamada, N., Nagase, T., Ozaki,
N., Ohara, O., Ishida, N., Okawa, M., Takahashi, K., Yamauchi, T., 2001.
Association of structural polymorphisms in the human period3 gene with
delayed sleep phase syndrome. EMBO Rep. 2, 342–346.
Finelli, L.A., Baumann, H., Borbély, A.A., Achermann, P., 2000. Dual
electroencephalogram markers of human sleep homeostasis: correlation
between theta activity in waking and slow-wave activity in sleep.
Neuroscience 101, 523–529.
Franken, P., Dijk, D.J., 2009. Circadian clock genes and sleep homeostasis.
Eur. J. Neurosci. 29, 1820–1829.
Jenkins, A., Archer, S.N., von Schantz, M., 2005. Expansion during pri-
mate radiation of a variable number tandem repeat in the coding region
of the circadian clock gene Period3. J. Biol. Rhythms 20, 470–472.
Knoblauch, V., Münch, M., Blatter, K., Martens, W.L., Schröder, C.,
Schnitzler, C., Wirz-Justice, A., Cajochen, C., 2005. Age-related
changes in the circadian modulation of sleep-spindle frequency during
nap sleep.Sleep 28, 1093–1101.
Landolt, H.P., 2008. Genotype-dependent differences in sleep, vigilance,
and response to stimulants. Curr. Pharm. Des. 14, 3396–3407.
Landolt, H.P., Dijk, D.J., Achermann, P., Borbély, A.A., 1996. Effect of
age on the sleep EEG: slow-wave activity and spindle frequency
activity in young and middle-aged men. Brain Res. 738, 205–212.
Lázár, A.S., Slak, A., Lo, J., Santhi, N., von Schantz, M., Archer, S.N., Groeger,
J.A., Dijk, D.J., in press. Sleep, diurnal preference, health and psychological
well-being: a prospective single-allelic variation study. Chronobiol Int.
Monk, T.H., 2005. Aging human circadian rhythms: conventional wisdom
may not always be right. J. Biol. Rhythms 20, 366–374.
Münch, M., Knoblauch, V., Blatter, K., Schröder, C., Schnitzler, C., Kräu-
chi, K., Wirz-Justice, A., Cajochen, C., 2004. The frontal predomi-
nance in human EEG delta activity after sleep loss decreases with age.
Eur. J. Neurosci. 20, 1402–1410.
Münch, M., Knoblauch, V.,Blatter, K., Schröder, C., Schnitzler, C.,Kräuchi, K.,
Wirz-Justice, A., Cajochen, C.,2005. Age-related attenuation of the evening
circadian arousal signal in humans. Neurobiol. Aging 26, 1307–1319.
Niggemyer, K.A., Begley, A., Monk, T., Buysse, D.J., 2004. Circadian and
homeostatic modulation of sleep in older adults during a 90-minute day
study. Sleep 27, 1535–1541.
Rechtschaffen, A., Kales, A., 1968. A manual of standardized terminology, tech-
niques and scoring system for sleep stages of human subjects. US Dept of
Health, Education and Welfare, Public Health Service, Bethesda, MD.
Rétey, J.V., Adam, M., Honegger, E., Khatami, R., Luhmann, U.F., Jung,
H.H., Berger, W., Landolt, H.P., 2005. A functional genetic variation of
adenosine deaminase affects the duration and intensity of deep sleep in
humans. Proc. Natl. Acad. Sci. U. S. A. 102, 15676–15681.
Steriade, M., McCormick, D.A., Sejnowski, T.J., 1993. Thalamocortical
oscillations in the sleeping and aroused brain. Science 262, 679–685.
Van Cauter, E., Leproult, R., Plat, L., 2000. Age-related changes in slow
wave sleep and REM sleep and relationship with growth hormone and
cortisol levels in healthy men. JAMA 284, 861–868.
Van Coevorden, A., Mockel, J., Laurent, E., Kerkhofs, M., L’Hermite-
Balèriaux, M., Decoster, C., Néve, P., Van Cauter, E., 1991. Neuroen-
docrine rhythms and sleep in aging men. Am. J. Physiol. Regul. Integr.
Comp. Physiol. 260, E651–E661.
Vandewalle, G., Archer, S.N., Wuillaume, C., Balteau, E., Degueldre, C.,
Luxen, A., Maquet, P., Dijk, D.J., 2009. Functional magnetic resonance
1010.e26 A.U. Viola et al. / Neurobiology of Aging 33 (2012) 1010.e17–1010.e27
imaging-assessed brain responses during an executive task depend on
interaction of sleep homeostasis, circadian phase, and PER3 genotype.
J. Neurosci. 29, 7948–7956.
Viola, A.U., Archer, S.N., James, L.M., Groeger, J.A., Lo, J.C., Skene,
D.J., Von Schantz, M., Dijk, D.J., 2007. PER3 polymorphism pre-
dicts sleep structure and waking performance. Curr. Biol. 17, 613–
618.
Weber, J.M., Schwander, J.C., Unger, I., Meier, D., 1997. A direct ultra-
sensitive RIA for the determination of melatonin in human saliva:
comparison with serum levels. J. Sleep Res. 26, 757.
Wei, H.G., Riel, E., Czeisler, C.A., Dijk, D.J., 1999. Attenuated amplitude
of circadian and sleep-dependent modulation of electroencephalo-
graphic sleep spindle characteristics in elderly human subjects. Neuro-
sci. Lett. 260, 29–32.
Weitzman, E.D., Moline, M.L., Czeisler, C.A., Zimmerman, J.C., 1982.
Chronobiology of aging: temperature, sleep-wake rhythms and entrain-
ment. Neurobiol. Aging 3, 299–309.
Zeitzer, J.M., Daniels, J.E., Duffy, J.F., Klerman, E.B., Shanahan, T.L.,
Dijk, D.J., Czeisler, C.A., 1999. Do plasma melatonin concentrations
decline with age? Am. J. Med. 107, 432–436.
1010.e27A.U. Viola et al. / Neurobiology of Aging 33 (2012) 1010.e17–1010.e27
